You're referring to the right to sell fee, which is one of the fees that we are proposing in the cost recovery in the proposal. It is a fee that we would apply to companies to have right of access to the market. It's a fee of just over $500 for a regular company, and there would be a 25% reduction if it's a small business.
In our estimation of the revenues from that fee line, we made an assumption that there are likely to be about 50,000 products on the market, not 200,000. We have authorized 200,000 products but, in consultation with stakeholders in the past, our estimate is that there are probably around 50,000 products on the market.